Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2060696> ?p ?o }
Showing triples 1 to 87 of
87
with 100 triples per page.
- Q2060696 subject Q7311092.
- Q2060696 subject Q8182050.
- Q2060696 subject Q8390828.
- Q2060696 abstract "Pirfenidone (INN, BAN) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF). It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II.It is a drug developed by several companies worldwide, including InterMune Inc. (now part of Roche), Shionogi Ltd., and GNI Group Ltd. In 2008, it was first approved in Japan for the treatment of IPF after clinical trials, under the trade name of Pirespa by Shionogi & Co. In October 2010, the Indian Company Cipla launched it as Pirfenex. In 2011, it was approved for use in Europe for IPF under the trade name Esbriet; it was approved in Canada in 2012 under the trade name Esbriet; and was approved in the United States in October 2014 under the same name. In September 2011, the Chinese State Food and Drug Administration provided GNI Group Ltd with new drug approval of pirfenidone in China, and later manufacture approval in 2013 under the trade name of Etuary.In 2014 it was approved in Mexico under the name KitosCell LP, indicated for pulmonary fibrosis and liver fibrosis. There is also a topical form created for the treatment of abnormal wound healing processes.".
- Q2060696 thumbnail Pirfenidone2DACS.svg?width=300.
- Q2060696 wikiPageExternalLink www.esbriet.com.
- Q2060696 wikiPageExternalLink esbriet_prescribing.pdf.
- Q2060696 wikiPageWikiLink Q101991.
- Q2060696 wikiPageWikiLink Q1070952.
- Q2060696 wikiPageWikiLink Q10916362.
- Q2060696 wikiPageWikiLink Q1105202.
- Q2060696 wikiPageWikiLink Q1163287.
- Q2060696 wikiPageWikiLink Q127076.
- Q2060696 wikiPageWikiLink Q130146.
- Q2060696 wikiPageWikiLink Q147778.
- Q2060696 wikiPageWikiLink Q14864427.
- Q2060696 wikiPageWikiLink Q14864434.
- Q2060696 wikiPageWikiLink Q14890102.
- Q2060696 wikiPageWikiLink Q14916181.
- Q2060696 wikiPageWikiLink Q14916187.
- Q2060696 wikiPageWikiLink Q152234.
- Q2060696 wikiPageWikiLink Q169219.
- Q2060696 wikiPageWikiLink Q176640.
- Q2060696 wikiPageWikiLink Q18032037.
- Q2060696 wikiPageWikiLink Q185557.
- Q2060696 wikiPageWikiLink Q186889.
- Q2060696 wikiPageWikiLink Q1929023.
- Q2060696 wikiPageWikiLink Q199602.
- Q2060696 wikiPageWikiLink Q2014823.
- Q2060696 wikiPageWikiLink Q204711.
- Q2060696 wikiPageWikiLink Q2112244.
- Q2060696 wikiPageWikiLink Q223591.
- Q2060696 wikiPageWikiLink Q2290446.
- Q2060696 wikiPageWikiLink Q256602.
- Q2060696 wikiPageWikiLink Q2585693.
- Q2060696 wikiPageWikiLink Q26868.
- Q2060696 wikiPageWikiLink Q269829.
- Q2060696 wikiPageWikiLink Q274515.
- Q2060696 wikiPageWikiLink Q285870.
- Q2060696 wikiPageWikiLink Q305481.
- Q2060696 wikiPageWikiLink Q32446.
- Q2060696 wikiPageWikiLink Q3482319.
- Q2060696 wikiPageWikiLink Q385009.
- Q2060696 wikiPageWikiLink Q407595.
- Q2060696 wikiPageWikiLink Q407693.
- Q2060696 wikiPageWikiLink Q408378.
- Q2060696 wikiPageWikiLink Q408471.
- Q2060696 wikiPageWikiLink Q409236.
- Q2060696 wikiPageWikiLink Q410061.
- Q2060696 wikiPageWikiLink Q411478.
- Q2060696 wikiPageWikiLink Q412474.
- Q2060696 wikiPageWikiLink Q415571.
- Q2060696 wikiPageWikiLink Q422210.
- Q2060696 wikiPageWikiLink Q422244.
- Q2060696 wikiPageWikiLink Q425056.
- Q2060696 wikiPageWikiLink Q427492.
- Q2060696 wikiPageWikiLink Q463418.
- Q2060696 wikiPageWikiLink Q4669898.
- Q2060696 wikiPageWikiLink Q5038318.
- Q2060696 wikiPageWikiLink Q5381545.
- Q2060696 wikiPageWikiLink Q581996.
- Q2060696 wikiPageWikiLink Q605709.
- Q2060696 wikiPageWikiLink Q608510.
- Q2060696 wikiPageWikiLink Q646347.
- Q2060696 wikiPageWikiLink Q653197.
- Q2060696 wikiPageWikiLink Q653971.
- Q2060696 wikiPageWikiLink Q660995.
- Q2060696 wikiPageWikiLink Q662511.
- Q2060696 wikiPageWikiLink Q7094.
- Q2060696 wikiPageWikiLink Q7180990.
- Q2060696 wikiPageWikiLink Q7200267.
- Q2060696 wikiPageWikiLink Q7311092.
- Q2060696 wikiPageWikiLink Q736033.
- Q2060696 wikiPageWikiLink Q8182050.
- Q2060696 wikiPageWikiLink Q824258.
- Q2060696 wikiPageWikiLink Q827658.
- Q2060696 wikiPageWikiLink Q8390828.
- Q2060696 wikiPageWikiLink Q8880.
- Q2060696 wikiPageWikiLink Q918753.
- Q2060696 type ChemicalSubstance.
- Q2060696 type Drug.
- Q2060696 type ChemicalObject.
- Q2060696 type Thing.
- Q2060696 type Q8386.
- Q2060696 comment "Pirfenidone (INN, BAN) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF). It works by reducing lung fibrosis through downregulation of the production of growth factors and procollagens I and II.It is a drug developed by several companies worldwide, including InterMune Inc. (now part of Roche), Shionogi Ltd., and GNI Group Ltd. In 2008, it was first approved in Japan for the treatment of IPF after clinical trials, under the trade name of Pirespa by Shionogi & Co.".
- Q2060696 label "Pirfenidone".
- Q2060696 depiction Pirfenidone2DACS.svg.